# Phase 1 hypertension trials recruiting: 37 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials in phase 1 for hypertension that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 hypertension trials: 37 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/hypertension

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 37
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07916961 | Study of AB-110 in Healthy and Hypertensive Participants | Antlia Bioscience, Inc | Phase 1 | Not yet recruiting | Hypertension (HTN), Healthy Adult Participants | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916961) |
| October 28, 2026 | NCT07901114 | A Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult Volunteers | AJU Pharm Co., Ltd. | Phase 1 | Not yet recruiting | Hypertension | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901114) |
| September 24, 2026 | NCT07838220 | A Study of IBI3016 in Japanese Participants | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 | Recruiting | Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838220) |
| September 4, 2026 | NCT07803835 | Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension | Shanghai Minwei Biotechnology Co., Ltd | Phase 1 | Recruiting | Essential Hypertension, Healthy Volunteers | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803835) |
| August 31, 2026 | NCT07795762 | Eplerenone and IOP in Healthy Adults | University of Florida | Phase 1 | Not yet recruiting | Intraocular Pressure (IOP), Healthy Adult | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795762) |
| August 25, 2026 | NCT07784621 | A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in... | Huons Co., Ltd. | Phase 1 | Not yet recruiting | Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784621) |
| July 6, 2026 | NCT07682948 | A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and... | Korea United Pharm. Inc. | Phase 1 | Recruiting | Hypertension, Dyslipidemia | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682948) |
| June 12, 2026 | NCT07644364 | HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension | Novartis Pharmaceuticals | Phase 1 | Recruiting | Elevated Blood Pressure, Hypertension | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07644364) |
| June 11, 2026 | NCT07641296 | Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With... | SpyGlass Pharma, Inc. | Phase 1 | Not yet recruiting | Glaucoma, Ocular Hypertension | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641296) |
| May 27, 2026 | NCT07609875 | A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese... | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Healthy Adult, Hypertension | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609875) |
| May 15, 2026 | NCT07590466 | A Study to Compare the Pharmacokinetics and Safety of the ATB-U101 and ATB-U1011+ATB-U1012 and ATB-1011+ATB-1012 in Healthy Caucasian... | Autotelicbio | Phase 1 | Not yet recruiting | Diabete Type 2, Hypertension | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590466) |
| May 15, 2026 | NCT07590167 | A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C | Addpharma Inc. | Phase 1 | Not yet recruiting | Dyslipidemia, Hypertension | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590167) |
| March 20, 2026 | NCT07486453 | Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 1 | Not yet recruiting | Primary Hypertension | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07486453) |
| February 23, 2026 | NCT07428473 | A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) | Monash University | Phase 1 | Recruiting | Elevated LDL-C and High Cholesterol | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428473) |
| February 19, 2026 | NCT07421414 | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2... | Boryung Pharmaceutical Co., Ltd | Phase 1 | Not yet recruiting | Essential Hypertension | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421414) |
| February 19, 2026 | NCT07421401 | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2... | Boryung Pharmaceutical Co., Ltd | Phase 1 | Not yet recruiting | Essential Hypertension | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421401) |
| February 19, 2026 | NCT07421388 | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2... | Boryung Pharmaceutical Co., Ltd | Phase 1 | Not yet recruiting | Essential Hypertension | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421388) |
| February 19, 2026 | NCT07421375 | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2... | Boryung Pharmaceutical Co., Ltd | Phase 1 | Not yet recruiting | Essential Hypertension | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421375) |
| January 26, 2026 | NCT07368088 | PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension | Samsung Medical Center | Phase 1 | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Premature Infants | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07368088) |
| December 31, 2025 | NCT07312799 | Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 | Addpharma Inc. | Phase 1 | Not yet recruiting | Hypertension | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312799) |
| December 31, 2025 | NCT07312773 | A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C | Addpharma Inc. | Phase 1 | Not yet recruiting | Hypertension, Hyperlipidemia | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312773) |
| November 28, 2025 | NCT07254481 | VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Phase 1 | Recruiting | Hypertension | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254481) |
| October 3, 2025 | NCT07206303 | The Effects of Bifidobacterium-based Probiotics in Reducing Blood Pressure in Middle-aged Chinese With Hypertension | The University of Hong Kong | Phase 1 | Not yet recruiting | Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07206303) |
| September 25, 2025 | NCT07191899 | To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension | Suzhou Alphamab Co., Ltd. | Phase 1 | Recruiting | Hypertension | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07191899) |
| May 25, 2025 | NCT06990204 | Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia) | Gedeon Richter Plc. | Phase 1 | Not yet recruiting | Hypertension | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06990204) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Boryung Pharmaceutical Co., Ltd](https://specstream.ai/data/clinical-trials/company/boryung-pharmaceutical-co-ltd) | 4 |
| [Addpharma Inc.](https://specstream.ai/data/clinical-trials/company/addpharma-inc) | 3 |
| SpyGlass Pharma, Inc. | 1 |
| Vanderbilt University | 1 |
| Samsung Medical Center | 1 |
| [Jiangsu Hansoh Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/jiangsu-hansoh-pharmaceutical-co-ltd) | 1 |
| University of Alberta | 1 |
| University of Florida | 1 |
| [Shanghai Minwei Biotechnology Co., Ltd](https://specstream.ai/data/clinical-trials/company/shanghai-minwei-biotechnology-co-ltd) | 1 |
| University of Alabama at Birmingham | 1 |
| The University of Hong Kong | 1 |
| [Huons Co., Ltd.](https://specstream.ai/data/clinical-trials/company/huons-co-ltd) | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| [Shenzhen Salubris Pharmaceuticals Co., Ltd.](https://specstream.ai/data/clinical-trials/company/shenzhen-salubris-pharmaceuticals-co-ltd) | 1 |
| Mayo Clinic | 1 |
| [Korea United Pharm. Inc.](https://specstream.ai/data/clinical-trials/company/korea-united-pharm-inc) | 1 |
| Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 1 |
| [AJU Pharm Co., Ltd.](https://specstream.ai/data/clinical-trials/company/aju-pharm-co-ltd) | 1 |
| Pharmosa Biopharm Inc. | 1 |
| Suzhou Alphamab Co., Ltd. | 1 |
| [Innovent Biologics (Suzhou) Co. Ltd.](https://specstream.ai/data/clinical-trials/company/innovent-biologics-suzhou-co-ltd) | 1 |
| Autotelicbio | 1 |
| [Beijing Continent Pharmaceutical Co, Ltd.](https://specstream.ai/data/clinical-trials/company/beijing-continent-pharmaceutical-co-ltd) | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| Sunnybrook Health Sciences Centre | 1 |

## By country

| Country | Trials |
| --- | --- |
| South Korea | 7 |
| United States | 7 |
| China | 6 |
| New Zealand | 3 |
| Canada | 2 |
| Japan | 2 |
| Hong Kong | 1 |
| Russia | 1 |
| Australia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Veterans hospitals in the United States](https://specstream.ai/data/businesses/veterans-hospitals/united-states)
- [Adult education centers in the United States](https://specstream.ai/data/businesses/adult-education-centers/united-states)
- [Automation companies in the United States](https://specstream.ai/data/businesses/automation-companies/united-states)
- [Bakeries in the United States](https://specstream.ai/data/businesses/bakeries/united-states)
- [Burmese restaurants in the United States](https://specstream.ai/data/businesses/burmese-restaurants/united-states)
- [Civil rights law firms in the United States](https://specstream.ai/data/businesses/civil-rights-law-firms/united-states)
